Skyrizi 75 MG/83 ML X 2 (150 MG) Dose Prefilled Syringe Pack

RxCUI
2166143
RxNorm name
Skyrizi 75 MG/83 ML X 2 (150 MG) Dose Prefilled Syringe Pack
Display name
Skyrizi 75 MG/83 ML X 2 (150 MG) Dose Prefilled Syringe Pack
Full name
Skyrizi 75 MG/83 ML X 2 (150 MG) Dose Prefilled Syringe Pack
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761105Skyrizirisankizumab-rzaa351(a)Disc2026-10-01
761262Skyrizirisankizumab-rzaa351(a)Rx2026-10-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7148c8eb-b39e-e20a-6494-a6df82392858{2 (0.83 ML risankizumab-rzaa 90.4 MG/ML Prefilled Syringe [Skyrizi]) } Pack [Skyrizi 150 MG Dose Syringe Pack] [BPCK] · Skyrizi 75 MG/83 mL X 2 (150 MG) Dose Prefilled Syringe Pack [PSN] · Skyrizi 75 MG/83 ML X 2 (150 MG) Dose Prefilled Syringe Pack [SY]3173These highlights do not include all the information needed to use SKYRIZI safely and effectively. See full prescribing information for SKYRIZI. SKYRIZI ® (risankizumab-rzaa) injection, for subcutaneous or intravenous use Initial U.S. Approval: 201920260319